Page last updated: 2024-12-06

4-(diethylamino)benzaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-(Diethylamino)benzaldehyde is a yellow crystalline solid used in the synthesis of various organic compounds. It is a key intermediate in the production of dyes, pharmaceuticals, and other fine chemicals. The compound is also a building block for the preparation of Schiff bases, which have applications in catalysis, materials science, and coordination chemistry. Its synthesis typically involves the reaction of N,N-diethylaniline with benzaldehyde in the presence of a catalyst, followed by oxidation of the resulting alcohol. Studies on 4-(diethylamino)benzaldehyde focus on its reactivity, its use in the synthesis of new functional materials, and its potential as a precursor for biologically active compounds. The compound is a versatile building block in organic synthesis and has been used in the preparation of a wide range of products with diverse applications.'

4-(diethylamino)benzaldehyde : A member of the class of benzaldehydes carrying a diethylamino substituent at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID67114
CHEMBL ID3416563
CHEBI ID86194
SCHEMBL ID195135
MeSH IDM0156278

Synonyms (58)

Synonym
p-diethylaminobenzaldehyde
ai3-05886
nsc 8782
einecs 204-377-4
4-diethylaminobenzaldehyde
nsc-8782
4-(diethylamino)benzaldehyde
p-formyl-n,n-diethylaniline
benzaldehyde, 4-(diethylamino)-
nsc8782
benzaldehyde, p-(diethylamino)-
120-21-8
p-(diethylamino)benzaldehyde
p-diethylaminobenzaldhyde
benzaldehyde,4-diethylamino
inchi=1/c11h15no/c1-3-12(4-2)11-7-5-10(9-13)6-8-11/h5-9h,3-4h2,1-2h
4-diethylaminobenzaldehyde, 99%
STK187548
D0463
AKOS000118909
A804467
4-(diethylamino)-benzaldehyde
s640xwl10h ,
unii-s640xwl10h
FT-0618338
PS-6119
n,n-diethyl-4-formylaniline
BP-21432
4-(diethylamino) benzaldehyde
4-(n,n-diethyl)aminobenzaldehyde
p-n,n-diethylaminobenzaldehyde
4-diethylamino benzaldehyde
p-diethylamino-benzaldehyde
SCHEMBL195135
4-(n,n-diethylamino)benzaldehyde
dtxcid901963
tox21_303895
cas-120-21-8
NCGC00357151-01
dtxsid0021963 ,
CHEBI:86194 ,
W-108483
diethylaminobenzaldehyde, p-
4-(n,n-diethylamine)benzaldehyde
p-(n,n-diethylamino)benzaldehyde
4-formyl-n,n-diethylaniline
4-n,n-diethylamino benzaldehyde
bdbm50076742
CHEMBL3416563 ,
F2190-0606
mfcd00003382
CS-W017361
Q27158973
EN300-18276
HY-W016645
SB66335
4-diethylamino-benzaldehyde
Z57772436
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitorAn EC 1.2.1.* (oxidoreductase acting on donor aldehyde/oxo group with NAD(+) or NADP(+) as acceptor) inhibitor that interferes with the action of aldehyde dehydrogenase (NAD(+)), EC 1.2.1.3.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
benzaldehydesAny arenecarbaldehyde that consists of a formyl substituted benzene ring and its substituted derivatives thereof.
tertiary amino compoundA compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups.
aromatic amineAn amino compound in which the amino group is linked directly to an aromatic system.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (11)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency39.91490.007215.758889.3584AID1224835
AR proteinHomo sapiens (human)Potency12.65310.000221.22318,912.5098AID1259243; AID1259247; AID1259381
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency49.26170.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency21.68990.000417.946075.1148AID1346795
retinoid X nuclear receptor alphaHomo sapiens (human)Potency0.71010.000817.505159.3239AID1159527; AID1159531
pregnane X nuclear receptorHomo sapiens (human)Potency48.55770.005428.02631,258.9301AID1346982
thyroid stimulating hormone receptorHomo sapiens (human)Potency61.13060.001628.015177.1139AID1259385
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Retinal dehydrogenase 1Homo sapiens (human)IC50 (µMol)1.03570.02001.04766.7900AID1199888; AID1199901; AID1387301; AID1387315; AID1387316; AID1826420
Aldehyde dehydrogenase, mitochondrialHomo sapiens (human)IC50 (µMol)15.00000.04003.40799.0000AID1387300
Aldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)IC50 (µMol)5.67001.20003.43505.6700AID1826422
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (33)

Processvia Protein(s)Taxonomy
retinoid metabolic processRetinal dehydrogenase 1Homo sapiens (human)
cellular aldehyde metabolic processRetinal dehydrogenase 1Homo sapiens (human)
gamma-aminobutyric acid biosynthetic processRetinal dehydrogenase 1Homo sapiens (human)
fructosamine catabolic processRetinal dehydrogenase 1Homo sapiens (human)
maintenance of lens transparencyRetinal dehydrogenase 1Homo sapiens (human)
retinol metabolic processRetinal dehydrogenase 1Homo sapiens (human)
cellular detoxification of aldehydeRetinal dehydrogenase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisRetinal dehydrogenase 1Homo sapiens (human)
carbohydrate metabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
alcohol metabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
ethanol catabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
aldehyde catabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
regulation of dopamine biosynthetic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
regulation of serotonin biosynthetic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
cellular aldehyde metabolic processAldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)
lipid metabolic processAldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)
xenobiotic metabolic processAldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)
optic cup morphogenesis involved in camera-type eye developmentAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
retinoic acid biosynthetic processAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
apoptotic processAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
locomotory behaviorAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
nucleus accumbens developmentAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
embryonic camera-type eye developmentAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
inner ear morphogenesisAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
retinol metabolic processAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
retinoic acid metabolic processAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
retinal metabolic processAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
positive regulation of apoptotic processAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
embryonic eye morphogenesisAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
neuromuscular process controlling balanceAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
protein homotetramerizationAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
righting reflexAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
olfactory pit developmentAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
face developmentAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
Harderian gland developmentAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (20)

Processvia Protein(s)Taxonomy
retinal dehydrogenase activityRetinal dehydrogenase 1Homo sapiens (human)
aldehyde dehydrogenase (NAD+) activityRetinal dehydrogenase 1Homo sapiens (human)
GTPase activator activityRetinal dehydrogenase 1Homo sapiens (human)
androgen bindingRetinal dehydrogenase 1Homo sapiens (human)
protein bindingRetinal dehydrogenase 1Homo sapiens (human)
aminobutyraldehyde dehydrogenase activityRetinal dehydrogenase 1Homo sapiens (human)
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activityRetinal dehydrogenase 1Homo sapiens (human)
NAD bindingRetinal dehydrogenase 1Homo sapiens (human)
3-deoxyglucosone dehydrogenase activityRetinal dehydrogenase 1Homo sapiens (human)
benzaldehyde dehydrogenase (NAD+) activityRetinal dehydrogenase 1Homo sapiens (human)
aldehyde dehydrogenase (NAD+) activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
aldehyde dehydrogenase [NAD(P)+] activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
phenylacetaldehyde dehydrogenase activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
electron transfer activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
nitroglycerin reductase activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
NAD bindingAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
carboxylesterase activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
aldehyde dehydrogenase (NAD+) activityAldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)
aldehyde dehydrogenase [NAD(P)+] activityAldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)
protein bindingAldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)
alcohol dehydrogenase (NADP+) activityAldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)
benzaldehyde dehydrogenase (NAD+) activityAldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)
3-chloroallyl aldehyde dehydrogenase activityAldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)
retinal dehydrogenase activityAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
aldehyde dehydrogenase [NAD(P)+] activityAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
protein homodimerization activityAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
thyroid hormone bindingAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
NAD+ bindingAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
aldehyde dehydrogenase (NAD+) activityAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
cytoplasmRetinal dehydrogenase 1Homo sapiens (human)
cytosolRetinal dehydrogenase 1Homo sapiens (human)
axonRetinal dehydrogenase 1Homo sapiens (human)
synapseRetinal dehydrogenase 1Homo sapiens (human)
extracellular exosomeRetinal dehydrogenase 1Homo sapiens (human)
mitochondrionAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
mitochondrial matrixAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
extracellular exosomeAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
extracellular spaceAldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)
endoplasmic reticulumAldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)
cytosolAldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)
plasma membraneAldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)
cytoplasmAldehyde dehydrogenase, dimeric NADP-preferring Homo sapiens (human)
cytoplasmAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
cytosolAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
extracellular exosomeAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (25)

Assay IDTitleYearJournalArticle
AID1387301Inhibition of human ALDH1A12018Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
AID1387327Inhibition of ALDH1A3 in human PEO1 cells assessed as reduction in aldefluor positive cells at 1 uM incubated for 30 mins by aldefluor assay2018Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
AID1387300Inhibition of ALDH (unknown origin)2018Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
AID1826435Cytotoxicity against human H415/15 cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue staining based analysis2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.
AID1826433Antiproliferative activity against human LNCaP cells expressing ALDH1A3 assessed as reduction in cell survival measured after 96 hrs by MTT assay2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.
AID1199901Inhibition of recombinant human ALDH1A1 using propionaldehyde as substrate preincubated for 2 mins with NAD+ followed by substrate addition by UV-Vis spectrophotometric analysis2015Journal of medicinal chemistry, Feb-26, Volume: 58, Issue:4
Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.
AID1199888Inhibition of human ALDH1A1 G458N mutant using propionaldehyde as substrate preincubated for 2 mins with NAD+ followed by substrate addition by UV-Vis spectrophotometric analysis2015Journal of medicinal chemistry, Feb-26, Volume: 58, Issue:4
Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.
AID1826437Cytotoxicity against human H431/14 LM cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue staining based analysis2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.
AID1387333Inhibition of ALDH1A3 in human PEO1 cells assessed as reduction in CD133 protein expression incubated for 48 hrs by CD133/2-APC antibody based assay2018Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
AID1826438Cytotoxicity against human H488/14 RM cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue staining based analysis2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.
AID1826434Antiproliferative activity against human DU145 cells expressing ALDH1A1 assessed as reduction in cell survival measured after 96 hrs by MTT assay2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.
AID1387314Inhibition of ALDH1A3 in human PEO1 cells assessed as reduction in aldefluor positive cells up to 30 uM incubated for 30 mins by aldefluor assay2018Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
AID1826422Inhibition of N-terminal-His6 tagged recombinant human ALDH3A1 assessed as reduction in NADPH production using 4-NBA and NADP+ as substrate by fluorimetric analysis2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.
AID1826421Inhibition of N-terminal-His6 tagged recombinant human ALDH1A3 assessed as reduction in NADH production using hexanal and NAD+ as substrate by fluorimetric analysis2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.
AID1387328Inhibition of ALDH1A3 in human PEO1 cells assessed as reduction in aldefluor positive cells at 10 uM incubated for 30 mins by aldefluor assay2018Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
AID1387334Inhibition of ALDH1A3 in human OVCAR5 cells assessed as reduction in CD133 protein expression incubated for 48 hrs by CD133/2-APC antibody based assay2018Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
AID1387330Inhibition of ALDH1A3 in human OVCAR5 cells assessed as reduction in aldefluor positive cells at 10 uM incubated for 30 mins by aldefluor assay2018Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
AID1826439Cytotoxicity against human H517/15 RM cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue staining based analysis2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.
AID1387315Inhibition of ALDH1A1 in human MIAPaCa2 cells assessed as reduction in aldefluor positive cells up to 30 uM incubated for 30 mins by aldefluor assay2018Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
AID1387316Inhibition of ALDH1A1 in human HT-29 cells assessed as reduction in aldefluor positive cells up to 30 uM incubated for 30 mins by aldefluor assay2018Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
AID1826436Cytotoxicity against human H568/15 RM cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue staining based analysis2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.
AID1387329Inhibition of ALDH1A3 in human OVCAR5 cells assessed as reduction in aldefluor positive cells at 1 uM incubated for 30 mins by aldefluor assay2018Journal of medicinal chemistry, 10-11, Volume: 61, Issue:19
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
AID1826419Inhibition of N-terminal-His6 tagged recombinant human ALDH1A1 assessed as remaining enzyme activity by measuring fluorescence of NADH using hexanal and NAD+ as substrate at 10 uM by fluorimetric analysis relative to control2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.
AID1826420Inhibition of N-terminal-His6 tagged recombinant human ALDH1A1 assessed as reduction in NADH production using hexanal and NAD+ as substrate by fluorimetric analysis2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.
AID1826432Antiproliferative activity against human PC-3 cells expressing ALDH1A1 and ALDH3A1 assessed as reduction in cell survival measured after 96 hrs by MTT assay2022Journal of medicinal chemistry, 03-10, Volume: 65, Issue:5
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.25)18.7374
1990's1 (6.25)18.2507
2000's3 (18.75)29.6817
2010's8 (50.00)24.3611
2020's3 (18.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.59 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.18 (4.65)
Search Engine Demand Index35.52 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]